Dementia and Alzheimer Disease

Epilepsy

Migraine

Headache and Migraine

MS Advanced Practice Providers

Multiple Sclerosis

NMOSD

MS and Demyelinating Disorders

Parkinson Disease

Movement Disorders

Ataxia

Chronic Inflammatory Demyelinating Polyneuropathy

Muscular Dystrophy

Neuromuscular

Insomnia

Narcolepsy

Sleep Disorders

Stroke

News

Media

All Videos

Medical World News

Podcasts

Weekly Recap

Cure Connections

Insights

Special Report

NeurologyLive Peer Exchange

Medcast

Peers & Perspectives

Roundtable Discussions

Conferences

Conference Coverage

Conference Listing

CME/CE

Partners

Publications

NeurologyLive

Bridging the Gaps

International Journal of MS Care

Resources

Expert Authors

FDA News

Features

Fellows' Corner

Future Leaders in Neurology

Giants of Multiple Sclerosis

Interactive Tools

Live Events

Neurology Resources

Virtual Events

Subscribe

Articles

Although valiltramiprosate failed to distinguish itself from placebo on the primary end point, the drug performed significantly better among mild MCI participants vs those with mild Alzheimer disease.

Valiltramiprosate Demonstrates Greater Promise in Milder Forms of Alzheimer Disease, Phase 3 APOLLOE4 Study Shows

Research suggests that CSF ATI ratios could serve as a biomarker for identifying patients with Alzheimer disease at higher risk of ARIA during lecanemab treatment, aiding in safer patient management.

Higher CSF Aß42/Total Tau Ratio Associated With Increased ARIA Risk in Lecanemab

Eli Lilly’s expanded LillyDirect platform tackles barriers in Alzheimer disease diagnosis and care, offering telehealth and in-person options through Healthgrades and Synapticure, with a focus on timely access and patient support.

Eli Lilly Announces Expanded Services to Early Diagnosis and Access Alzheimer Disease Care

Videos

The professor of neurology at the University of Texas Health Science Center San Antonio provided clinical insights on the genetic basis of oculopharyngeal muscular dystrophy, as well as the primary challenges in diagnosing and treating the condition. [WATCH TIME: 5 minutes]

Insights into OPMD and Advancements in Genetic Research: Matthew Wicklund, MD

Senior vice president of research at The ALS Association. 

The senior vice president of research at The ALS Association talked about a multidisciplinary session presented at the 2025 MDA Conference that highlighted diverse strategies for neural repair, from pharmacological targets to noninvasive brain stimulation. [WATCH TIME: 6 minutes]

Exploring Multimodal Approaches to Neural Regeneration: Kuldip Dave, PhD

Marco Meglio, Assistant Managing Editor for 

, has been with the team since October 2019. Follow him on Twitter 

In this final episode, neurologists discuss the role of advanced imaging, like OCT, in diagnosing and managing MS, emphasizing the need for further research to optimize its clinical application. [WATCH TIME: 2 minutes]

Bridging Neurology and Ophthalmology in Multiple Sclerosis Research

A pair of neurologists provide clinical insight on the difficulties with identifying and differentiating optic neuritis in various autoimmune conditions like multiple sclerosis and neuromyelitis optica spectrum disorder. [WATCH TIME: 4 minutes]

Challenges in Diagnosing Optic Neuritis in MS and MOGAD

In this third episode, experts delve into the evolving role of optic neuritis and the central vein sign in refining multiple sclerosis diagnosis, highlighting their significance in distinguishing MS from other conditions and ensuring accurate patient care. [WATCH TIME: 3 minutes]

Educating the Clinical Community on Changes to MS Diagnostic Criteria

NeurologyLive is your direct connection to the latest neurology news and interviews with expert neurologists in multimedia formats.

About Us

Advisory Board

Editorial

Contact Us

Advertise

Contact MJH LS

Do Not Sell My Information

Terms and Conditions

Privacy

NeurologyLive – Clinical Neurology News and Neurology Expert Insights

Facebook

LinkedIN

YouTube

Spotlight

ACTRIMS 2025

MDA 2025

Clinical Focus

Dementia/Alzheimer

Headache/Migraine

Video Series

News Network

 video series brings together pairs of expert clinicians and physicians to independently provide their insights on the latest and most up-to-date clinical care for specific neurologic diseases and disorders.

1rem

David Kudrow, MD, provides a discussion on the available treatment options for migraine management and prevention.

Expert Perspectives on the Management of Acute and Preventative Migraine

Expert neurologist and sleep specialist Chris Winter, MD, provides practical perspectives on the identification and management of narcolepsy and excessive daytime sleepiness.

Expert Perspectives on the Management of Narcolepsy and Excessive Daytime Sleepiness 

Insight from expert neurologist Peter A. LeWitt, MD, who reviews available on-demand therapies for patients with Parkinson’s disease experiencing morning OFF episodes.

Treating Morning OFF Episodes in Parkinson’s Disease

Expert neurologists discuss patient cases involving the treatment of adult-onset spinal muscular atrophy (SMA). 

Case-Based Insights: Expert Perspectives on the Treatment of Adult-Onset SMA

John Brandsema, MD, and Julie Parsons, MD, review the diagnosis and optimal management of spinal muscular atrophy.

Treating Spinal Muscular Atrophy (SMA)

An expert neurologist provides insight into epilepsy treatments and various factors that impact patient compliance. 

Patient Compliance with Treatments for Epilepsy

Key opinion leaders in the management of relapsing/remitting multiple sclerosis, Enrique Alvarez, MD, PhD and Lawrence Steinman, MD, review key factors to consider when using high-efficacy therapies and provide an overview of emerging data for potential new treatment options.  

Use of High-Efficacy Therapies for Treatment of Relapsing Multiple Sclerosis

Key opinion leaders in neurology Tanuja Chitnis, MD and Lauren B. Krupp, MD discuss the diagnosis and treatment of pediatric multiple sclerosis (MS) and provide insight into the impact that  results from the PARADIGM trial of fingolimod in pediatric patients may have on the treatment landscape. 

Diagnosis and Management of Multiple Sclerosis in Pediatric Patients

Expert Perspectives: Advances in the Management of Acute Migraine

Amit Verma, MD, reviews challenging epilepsy cases and their treatment. 

Case-Based Insights: Expert Perspectives on the Treatment of Epilepsy 

David Dodick, MD, and Robert Cowan, MD, FAAN, review changes to the treatment landscape for acute migraine. 

The Changing Treatment Landscape for Acute Migraine

Updates in Treatment of Adult Spinal Muscular Atrophy 

Management of Duchenne Muscular Dystrophy

Case Based Insights: Parkinson Disease OFF Episodes

Contemporary Data on Treating Multiple Sclerosis Exacerbations

Management of Neurofibromatosis Type 1 with Plexiform Neurofibromas (NF1 with PNs)